Stocks
Funds
Screener
Sectors
Watchlists
CME

CME - CME Group Inc Stock Price, Fair Value and News

$286.08+1.60 (+0.56%)
Market Closed

48/100

CME

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

48/100

CME

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$244

Target 3M

$272.55

Target 6M

$262.66

CME Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CME Price Action

Last 7 days

2.5%

Last 30 days

2.8%

Last 90 days

8.8%

Trailing 12 Months

22.1%

CME RSI Chart

CME Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CME Valuation

Market Cap

102.9B

Price/Earnings (Trailing)

27.34

Price/Sales (Trailing)

16.08

EV/EBITDA

19.94

Price/Free Cashflow

25.19

CME Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$244

Target 3M

$272.55

Target 6M

$262.66

CME Fundamentals

CME Revenue

Revenue (TTM)

6.4B

Rev. Growth (Yr)

-2.95%

Rev. Growth (Qtr)

-9.13%

CME Earnings

Earnings (TTM)

3.8B

Earnings Growth (Yr)

-0.53%

Earnings Growth (Qtr)

-11.42%

CME Profitability

EBT Margin

77.05%

Return on Equity

13.35%

Return on Assets

2.01%

Free Cashflow Yield

3.97%

CME Investor Care

Dividend Yield

3.74%

Dividend/Share (TTM)

10.7

Shares Dilution (1Y)

0.09%

Diluted EPS (TTM)

10.32

CME Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20256.3B6.4B6.4B0
20245.6B5.8B6.0B6.1B
20235.8B6.8B7.5B5.6B
20224.8B3.9B3.5B5.7B
20214.6B4.6B4.6B4.7B
20205.2B5.1B4.9B4.9B
20194.4B4.6B5.0B4.9B
20183.8B4.0B4.0B4.3B
20173.6B3.6B3.7B3.6B
20163.4B3.5B3.5B3.6B
20153.2B3.3B3.4B3.3B
20143.0B2.9B3.0B3.1B
20132.9B2.9B2.9B2.9B
20123.2B3.2B3.0B2.9B
20113.1B3.2B3.3B3.3B
20100003.0B
CME
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
 CEO
 WEBSITEcmegroup.com
 SECTORFinancial Services
 INDUSTRYFinancial Data & Stock Exchanges
 EMPLOYEES3460

CME Group Inc Frequently Asked Questions


CME is the stock ticker symbol of CME Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of CME Group Inc is 102.89 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CME's fair value in chart for subscribers.

The fair value guage provides a quick view whether CME is over valued or under valued. Whether CME Group Inc is cheap or expensive depends on the assumptions which impact CME Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CME.

As of Wed Jan 28 2026, CME's PE ratio (Price to Earnings) is 27.34 and Price to Sales (PS) ratio is 16.08. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CME PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, CME Group Inc has provided 0.123 (multiply by 100 for percentage) rate of return.